Mutations in Isocitrate Dehydrogenase (IDH) genes are more frequent in secondary GBM, where they reach 73% of the clinical cases, while in primary GBM, the percentage of IDH mutated tumors is barely 3.7% [3]. Here, IDH3A is linked to glioblastoma.